MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Bradykinesia"

  • 2022 International Congress

    Remote keyboard tapping: potential signatures of early motor dysfunction in isolated REM sleep behaviour disorder

    C. Simonet, L. Perez-Carbonell, H. Chohan, N. Akram, H. Li, A. Gill, J. Bestwick, A. Lees, A. Schrag, A. Noyce (London, United Kingdom)

    Objective: To compare keyboard tapping performance in people with iRBD with controls. Background: The Distal Finger Tapping (DFT)1 test and BRadykineisa Akinesia Incoordination test (BRAIN)2…
  • 2022 International Congress

    Ocular ping pong movement to disentangle apathy from Bradykinesia in Parkinson’s disease

    F. Rey, A. Zacharia, P. Krack, D. Benis, M. Bereau, R. Ptak, G. Allali, J. Bally (Geneva, Switzerland)

    Objective: To disentangle bradykinesia from apathy through analysis of ocular movements. Background: While Parkinson's disease (PD) is mainly characterized by motor symptoms such as bradykinesia,…
  • 2022 International Congress

    Clinical Manifestations Of Mn-Induced Parkinsonism In The Workers Of Manganese Ferroalloy Ore

    O. Koniashvili, G. Muzashvili, G. Khachiashvili, D. Daraselia, L. Gabunia (Tbilisi, Georgia)

    Objective: We aimed to assess the clinical characteristics and symptoms of chronic manganese intoxication in workers involved in grinding the manganese ore in the Zestafoni…
  • 2022 International Congress

    Pallidal beta activity correlates with stimulation-induced bradykinesia in dystonia patients

    R. Lofredi, U. Scheller, A. Mindermann, J. Krauss, A. Saryyeva, GH. Schneider, A. Kühn (Berlin, Germany)

    Objective: Identify a neurophysiological correlate of stimulation-induced bradykinesia in dystonia Background: Bradykinesia is a known side-effect of pallidal deep brain stimulation (DBS) in dystonia patients…
  • 2022 International Congress

    Determinants of symptom severity in Parkinson’s disease: the International Vacation Survey

    J. Janssen Daalen, J. Hubbers, M. Sharifi Bonab, S. Mathur, D. Thijssen, B. Bloem, M. Meinders (Nijmegen, Netherlands)

    Objective: As insight in the drivers of varying symptom severity might help manage symptoms, this study investigates the association between symptom severity and contextual factors…
  • 2022 International Congress

    Effects of Virtual Reality Immersion Level on Exercise Intensity and Motivation for Persons with Parkinson Disease

    J. Palmieri, R. Gallagher, J. Donoghue, N. Volino, H. Damodaran, J. Deutsch (Newark, USA)

    Objective: The purpose of this study was to determine the effect of immersion level in virtual reality (VR) on exercise intensity and motivation for persons…
  • MDS Virtual Congress 2021

    Supervised, home-based, real-time videoconferencing telerehabilitation preserves perception of some clinical aspects in people with Parkinson’s disease: preliminary data of a retrospective study

    E. Tardelli, E. Okamoto, F. Almeida, AM. Neto, E. Barbosa, C. Batista (São Paulo, Brazil)

    Objective: To compare retrospectively the effects of 10 months of supervised, home-based, real-time videoconferencing telerehabilitation (RTT) and usual care without exercise training (UC) on self-reported…
  • MDS Virtual Congress 2021

    Emerging parkinsonism in the PREDICT-PD cohort after 6-years of follow-up

    C. Simonet, A. Gill, J. Bestwick, A. Lees, G. Giovannoni, A. Schrag, A. Noyce (London, United Kingdom)

    Objective: To determine how motor features emerge over time in individuals estimated to be at higher risk of Parkinson’s disease (PD), compared with lower risk…
  • MDS Virtual Congress 2021

    Prasinezumab reduced progression of Parkinson’s disease motor features measured by Roche PD Mobile Application v2 sensor features: PASADENA Phase II Part 1

    K. Taylor, F. Lipsmeier, E. Volkova-Volkmar, D. Rukina, J. Anzures Cabrera, L. Essioux, M. Abt, B. van Lier, A. Thomann, H. Svoboda, W. Zago, R. Postuma, G. Pagano, M. Lindemann (Basel, Switzerland)

    Objective: To determine whether digital biomarker sensor data detect slowing in progression of core motor features of Parkinson’s disease (PD) in individuals with early PD…
  • MDS Virtual Congress 2021

    Early-onset vs. Late-onset Parkinson’s disease

    H. Slimène, N. Farhat, S. Sakka, O. Hdiji, M. Dammak, C. Mhiri (Sousse, Tunisia)

    Objective: To determine the clinical and therapeutic peculiarities that distinguish Early onset Parkinson’s disease (EOPD) from late onset Parkinson’s disease (LOPD). Background: Age is the…
  • « Previous Page
  • 1
  • …
  • 9
  • 10
  • 11
  • 12
  • 13
  • …
  • 27
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley